《新股表現》Vesync(02148.HK)上市翌日股價續漲28%曾見11.42元新高
Vesync(02148.HK)繼首掛日急漲逾59%每手賬面賺3,280元後,上市翌日股價進一步升破上周五盤中所創高位10.48元,最高見11.42元,現造11.26元,續漲28%,成交5,958萬股,涉資6.04億元。
深圳Vesync專注於線上銷售自主設計開發的小家電及智能家居設備,亞馬遜是其主要線上銷售平台。該公司的產品主要銷往美國、加拿大、英國、德國、法國、西班牙、意大利及日本等海外市場。是次來港上市共發售2.81億股,公開發售獲537倍超購,認購一手中籤率僅1.54%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.